Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Meng-Cheong Wong is active.

Publication


Featured researches published by Meng-Cheong Wong.


Movement Disorders | 2001

Restless legs syndrome in an Asian population: A study in Singapore

Eng-King Tan; A.B.H. Seah; S.J. See; E. Lim; Meng-Cheong Wong; K.K. Koh

In face‐to‐face interviews, we examined 157 consecutive individuals aged 55 years and older, selected from the general population in Singapore, and 1,000 consecutive individuals aged 21 years and older, from a primary healthcare center. Based on the IRLSSG criteria, the prevalence of restless leg syndrome (RLS) was 0.6% and 0.1%, respectively.


Neurology | 2002

Evaluation of somnolence in Parkinson’s disease: Comparison with age- and sex-matched controls

Ene-Choo Tan; S. Y. Lum; Stephanie Fook-Chong; M.L. Teoh; Y. Yih; Louis C. Tan; A. Tan; Meng-Cheong Wong

Abstract—The authors found a significantly higher prevalence of daytime somnolence in 201 patients with PD compared with 214 age- and sex-matched healthy control subjects (Epworth Sleepiness Scale score 5.6 vs 4.6). The prevalence of “sleep attacks” (SA) was about seven times higher in patients with PD than in control subjects (13.9% vs 1.9%;p < 0.0005). Multivariate analysis demonstrated that a higher dose of levodopa and longer duration of disease significantly predicted for SA in patients with PD. Epworth Sleepiness Scale scores of ≥10 had 71.4% sensitivity and 88.4% specificity for SA.


Journal of the Neurological Sciences | 2003

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese

Eng-King Tan; Chris Tan; Stephanie Fook-Chong; Sau-Ying Lum; Anthea Chai; Henry Chung; Hui Shen; Yi Zhao; Mei-Lin Teoh; Y. Yih; R. Pavanni; V. R. Chandran; Meng-Cheong Wong

INTRODUCTION Few studies have examined the relationship of coffee and tea in Parkinsons disease (PD). The potential protective effect of coffee intake and risk of PD has not been studied in a Chinese population. There is a high prevalence of caffeine takers among Chinese in our population. OBJECTIVE We undertook a case control study to examine the relationship between coffee and tea drinking, cigarette smoking, and other enviromental factors and risk of PD among ethnic Chinese in our population. METHODS AND RESULTS 300 PD and 500 population controls were initially screened. Two hundred case control pairs matched for age, gender, and race were finally included in the analysis. Univariate analysis revealed significant association of PD with coffee drinking (p<0.0005), tea drinking (p=0.019), alcohol drinking (p=0.001), cigarette smoking (p<0.0005), and exposure to heavy metals (p=0.006). Conditional logistic regression analysis demonstrated that amount of coffee drunk (OR 0.787, 95%CI 0.664-0.932, p=0.006), amount of tea drunk (OR 0.724, 95%CI 0.559-0.937, p=0.014), number of cigarettes smoked (OR 0.384, 95%CI 0.204-0.722, p=0.003), history of heavy metal and toxin exposure (OR 11.837, 95%CI 1.075-130.366, p=0.044), and heart disease (OR 5.518, 95%CI 1.377-22.116, p=0.016) to be significant factors associated with PD. One unit of coffee and tea (3 cups/day for 10 years) would lead to a 22% and 28% risk reduction of PD. One unit of cigarette smoke (3 packs/day for 10 years) reduced the risk of PD by 62%. CONCLUSIONS We demonstrated a dose-dependent protective effect of PD in coffee and tea drinkers and smokers in an ethnic Chinese population. A history of exposure to heavy metals increased the risk of PD, supporting the multifactorial etiologies of the disease.


Neuroscience Letters | 2005

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients

Eng-King Tan; Hui Shen; Louis C. Tan; Matthew J. Farrer; K. Yew; E. Chua; R.D. Jamora; K. Puvan; K.Y. Puong; Yi Zhao; R. Pavanni; Meng-Cheong Wong; Y. Yih; Lisa Skipper; Jianjun Liu

A common heterozygous leucine-rich repeat kinase 2 (LRRK2) mutation 6055G > A transition (G2019S) accounts for about 3-7% of familial Parkinsons disease (PD) and 1-1.6% sporadic PD in a number of European populations. To determine the prevalence of the G1019S mutation in our Asian population, we conducted genetic analysis of this mutation in 1000 PD and healthy controls. The G2019S mutation was not detected in any of our study subjects. The prevalence of G2019S mutation is rare (< 0.1%) in our population, suggesting that occurrence of this mutation may vary amongst different ethnic races. This has important clinical implication when implementing guidelines for genetic testing.


Stroke | 2007

South Asian Patients With Ischemic Stroke Intracranial Large Arteries Are the Predominant Site of Disease

Deidre A. De Silva; Fung-Peng Woon; Moi-Pin Lee; Christopher P. Chen; Hui-Meng Chang; Meng-Cheong Wong

Background and Purpose— South Asians are the most prevalent ethnic group in the world. Intracranial disease is the most common vascular lesion worldwide. Methods— We prospectively studied 200 consecutive ethnic South Asian patients with acute ischemic stroke in Singapore. Results— Intracranial large-artery disease was prevalent among 54% of all stroke subtypes and was independently associated with hypertension and higher serum erythrocyte sedimentation rate. Conclusions— Among ethnic South Asian patients with ischemic stroke, intracranial large arteries are the predominant site of disease.


Neurology | 2004

Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease

Ene-Choo Tan; A. Chai; Y. Y. Teo; Yi Zhao; C. Tan; H. Shen; V. R. Chandran; M. L. Teoh; Y. Yih; R. Pavanni; Meng-Cheong Wong; K. Puvan; Y. L. Lo; E. Yap

The authors examined four- and six-loci haplotype constructs (from five single nucleotide polymorphisms and three microsatellite regions) of the alpha-synuclein gene in patients with Parkinson’s disease (PD) and controls in an ethnic Chinese population. Logistic regression analysis demonstrated an association of NACP-Rep1 (p = 0.002) and L478 (p < 0.0001) with risk of PD after correction for the effects of age, sex, and the other polymorphic loci. Specific four-loci and six-loci haplotypes were significantly associated with an increased or decreased risk of PD.


Movement Disorders | 2006

PINK1 mutations in sporadic early‐onset Parkinson's disease

Eng-King Tan; Kenneth Yew; Eva Chua; K. Puvan; Hui Shen; Esther Lee; K. Y. Puong; Yi Zhao; R. Pavanni; Meng-Cheong Wong; Dominic Jamora; Deidre A. De Silva; Kyaw‐Thu Moe; Fung-Peng Woon; Yih Yuen; Louis C.S. Tan

Pathogenic PINK1 mutations have been described in PARK6‐linked Parkinsons disease (PD) patients of Asian origin. However, data on the frequency of PINK1 mutations in sporadic early‐onset Parkinsons disease (EOPD) Asian patients are lacking. The objectives of this study were to report the frequency of PINK1 mutations of sporadic EOPD in an Asian cohort comprising of ethnic Chinese, Malays, and Indians, and to highlight a PINK1‐positive patient who presented with restless legs symptoms. Eighty consecutive sporadic EOPD patients from the movement disorder clinics of two major tertiary institutions in the country were included. We performed sequence analysis of all the coding and exon–intron junctions of the PINK1 using specific primer sets. In addition, we genotyped polymorphisms detected from the analysis in a group of sporadic PD patients and controls. Three different mutations (two homozygous nonsense and one heterozygous missense) in the putative kinase domain were found in three patients, giving a 3.7% frequency of PINK1 mutations in our EOPD cohort. All the mutations were absent in 200 healthy controls. One patient with a novel homozygous nonsense PINK1 mutation presented unusually with restless legs symptoms. Separately, analysis of the frequency of four PINK1 polymorphisms in a group of sporadic PD and controls did not reveal any significant differences. We highlight a 3.7% frequency of PINK1 mutations in an Asian cohort (ethnic Chinese, Malay, and Indian) of EOPD. The phenotypic spectrum associated with PINK1‐positive patients may be wider than previously reported. Polymorphisms of PINK1 do not appear to modulate risk of PD in our population.


Neurology | 2005

Analysis of LRRK2 functional domains in nondominant Parkinson disease.

L. Skipper; H. Shen; E. Chua; C. Bonnard; P. Kolatkar; Louis C. Tan; R.D. Jamora; K. Puvan; K. Y. Puong; Yi Zhao; R. Pavanni; Meng-Cheong Wong; Yih Yuen; Matthew J. Farrer; Jianjun Liu; Eng-King Tan

A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant Parkinson disease (PD) patients was performed. Novel variant screening in a further 470 sporadic PD patients and 630 controls revealed two novel variants (R1067Q and IVS33 + 6 T>A), which are likely to be pathogenic in five patients. One patient presented initially with a typical essential tremor phenotype, expanding the phenotypic spectrum of LRRK2 mutations.


Neurology | 2004

Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort

Ene-Choo Tan; Yi Zhao; K. Y. Puong; H. Y. Law; Ling-Ling Chan; K. Yew; C. Tan; H. Shen; V. R. Chandran; M. L. Teoh; Y. Yih; R. Pavanni; Meng-Cheong Wong; I. S. Ng

Among 367 subjects, the authors analyzed 167 patients with essential tremor, sporadic progressive cerebellar ataxia, multiple-system atrophy, and atypical parkinsonism and 200 healthy control subjects for FMR1 premutation alleles. None of the subjects carried alleles within the premutation range. These findings suggest that in the absence of other supportive clinical or imaging features, the cost-effectiveness of routine fragile X tremor/ataxia syndrome screening in this Asian cohort with movement disorders was low.


Neuroscience Letters | 2003

Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.

Eng-King Tan; Chris Tan; Hui Shen; Anthea Chai; Sau-Ying Lum; Mei-Lin Teoh; Yuan Yih; Meng-Cheong Wong; Yi Zhao

Polymorphism of the alpha synuclein promoter region (non-amyloid component of plaques (NACP)-Rep1) is associated with an increased risk of Parkinsons disease (PD) in three separate studies. We studied NACP-Rep1 polymorphism in two independent case control studies in our population. In study one, 104 PD and 104 age, gender and race matched controls; and in study two, 102 PD and 102 age, gender and race matched controls were examined separately. The results of both studies were analyzed independent of one another. We found three polymorphic alleles (designated 0, 1, 2). In study one, the frequency of allele 2 was significantly higher in PD patients as compared to healthy controls (0.37 versus 0.23, P=0.01, X(2)=9.98). In study two, the frequency of allele 2 was similar between PD and controls (0.31 versus 0.33, P=1.00, X(2)=0.30). There was a non-significant higher allele 2 frequency in PD when both studies were analyzed together (0.34 versus 0.28, P=0.20, X(2)=3.4). No significant differences of the various genotypes between PD and controls were found. However there were differences of the mixed dinucleotide repeats sequences for similar homozygous genotypes. Variability of the microsatellite region and potential interacting factors that could affect alpha synuclein gene transcription should be further examined.

Collaboration


Dive into the Meng-Cheong Wong's collaboration.

Top Co-Authors

Avatar

Eng-King Tan

National University of Singapore

View shared research outputs
Top Co-Authors

Avatar

Yi Zhao

Singapore General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hui-Meng Chang

Singapore General Hospital

View shared research outputs
Top Co-Authors

Avatar

R. Pavanni

Singapore General Hospital

View shared research outputs
Top Co-Authors

Avatar

Christopher P. Chen

National University of Singapore

View shared research outputs
Top Co-Authors

Avatar

Fung-Peng Woon

Singapore General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hui Shen

Singapore General Hospital

View shared research outputs
Top Co-Authors

Avatar

Ling-Ling Chan

Singapore General Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge